Barnett & Company, Inc. Astrazeneca PLC Transaction History

Barnett & Company, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$55.72 - $67.12 $6,407 - $7,718	-115 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$54.02 - $63.83 $6,212 - $7,340	115 New	115 $7,000
Q2 2021 Jul 20, 2021	SELL	$48.42 - $60.18 $1.33 Million - $1.65 Million	-27,500 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$47.16 - $54.44 $94,320 - $108,880	2,000 Added 7.84%	27,500 $1.37 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $203,784 - $243,684	-4,200 Reduced 14.14%	25,500 $1.27 Million
Q3 2020 Nov 03, 2020	BUY	$53.07 - $61.1 $79,605 - $91,650	1,500 Added 5.32%	29,700 $1.63 Million
Q2 2020 Jul 22, 2020	BUY	$43.1 - $55.31 $1.22 Million - $1.56 Million	28,200 New	28,200 $1.49 Million
Q4 2017 Feb 02, 2018	SELL	$32.09 - $34.78 $5,198 - $5,634	-162 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$28.96 - $34.0 $4,691 - $5,508	162	162 $5,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Barnett & Company, Inc. with notifications on news.